By Annaldas Shivaraju, M.S. (Pharm.), Freyr Global Regulatory Solutions and Services
Carcinogenicity assessments often rely heavily on two-year rodent bioassays. The weight of evidence (WoE) approach seeks to streamline this process, combining thorough science with regulatory practicality.
